Kintara Therapeutics Inc (KTRA)

Kintara Therapeutics Stock (KTRA) dropped by 79.68% from $3.76 to $0.764 in the trading on Tuesday October 31, 2023. The reason why KTRA stock down today is due to VAL-083 failure. The company has announced that their drug VAL-083 did not outperform existing treatments for glioblastoma, a severe brain cancer. Kintara is discontinuing the development of VAL-083 and shifting their focus to REM-001, a localized tumor treatment. Kintara will also explore strategic options to maximize shareholder value.